Cargando…

Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma

The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Carmela, Rinaldo, Nicola, Bruni, Paola, Malzoni, Carmine, Zullo, Fulvio, Fabiani, Fernanda, Losito, Simona, Scrima, Marianna, Marino, Federica Zito, Franco, Renato, Quintiero, Alfina, Agosti, Valter, Viglietto, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567053/
https://www.ncbi.nlm.nih.gov/pubmed/23408974
http://dx.doi.org/10.1371/journal.pone.0055362
_version_ 1782258651576139776
author De Marco, Carmela
Rinaldo, Nicola
Bruni, Paola
Malzoni, Carmine
Zullo, Fulvio
Fabiani, Fernanda
Losito, Simona
Scrima, Marianna
Marino, Federica Zito
Franco, Renato
Quintiero, Alfina
Agosti, Valter
Viglietto, Giuseppe
author_facet De Marco, Carmela
Rinaldo, Nicola
Bruni, Paola
Malzoni, Carmine
Zullo, Fulvio
Fabiani, Fernanda
Losito, Simona
Scrima, Marianna
Marino, Federica Zito
Franco, Renato
Quintiero, Alfina
Agosti, Valter
Viglietto, Giuseppe
author_sort De Marco, Carmela
collection PubMed
description The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110α catalytic subunit of PI3K (63/93, ∼68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110α overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110α overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration.
format Online
Article
Text
id pubmed-3567053
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35670532013-02-13 Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma De Marco, Carmela Rinaldo, Nicola Bruni, Paola Malzoni, Carmine Zullo, Fulvio Fabiani, Fernanda Losito, Simona Scrima, Marianna Marino, Federica Zito Franco, Renato Quintiero, Alfina Agosti, Valter Viglietto, Giuseppe PLoS One Research Article The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110α catalytic subunit of PI3K (63/93, ∼68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110α overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110α overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration. Public Library of Science 2013-02-07 /pmc/articles/PMC3567053/ /pubmed/23408974 http://dx.doi.org/10.1371/journal.pone.0055362 Text en © 2013 De Marco et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
De Marco, Carmela
Rinaldo, Nicola
Bruni, Paola
Malzoni, Carmine
Zullo, Fulvio
Fabiani, Fernanda
Losito, Simona
Scrima, Marianna
Marino, Federica Zito
Franco, Renato
Quintiero, Alfina
Agosti, Valter
Viglietto, Giuseppe
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title_full Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title_fullStr Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title_full_unstemmed Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title_short Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
title_sort multiple genetic alterations within the pi3k pathway are responsible for akt activation in patients with ovarian carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567053/
https://www.ncbi.nlm.nih.gov/pubmed/23408974
http://dx.doi.org/10.1371/journal.pone.0055362
work_keys_str_mv AT demarcocarmela multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT rinaldonicola multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT brunipaola multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT malzonicarmine multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT zullofulvio multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT fabianifernanda multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT lositosimona multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT scrimamarianna multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT marinofedericazito multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT francorenato multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT quintieroalfina multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT agostivalter multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma
AT vigliettogiuseppe multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma